Panel Directs Board To Reconsider Skin Cancer Patent Holding

Mealey's (February 19, 2021, 12:52 PM EST) -- WASHINGTON, D.C. — In a Feb. 18 ruling, the Federal Circuit U.S. Court of Appeals said the Patent Trial and Appeal Board erred in confirming as patentable two independent claims of...

To view the full article, register now.